<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Brain tumor":1,
"CNS sarcoma":1,
"Ciliary body medulloepithelioma":1,
"DICER1":1,
"DICER1-associated CNS sarcoma":1,
"ETMR":1,
"Pineoblastoma":1,
"Pituitary blastoma":1,
"CCL8":1,
"HERC5":1,
"RSAD2":1,
"breast cancer prognosis":1,
"weighted gene correlation network analysis":1,
"Chromophobe renal cell carcinoma":1,
"MALDI":1,
"Profiling ESI":1,
"Renal cancer":1,
"Renal oncocytoma":1,
"Sequential extraction":1,
"Nodular goiter":1,
"Thyroid cancer":23,
"acute kidney injury":1,
"functional parathyroid cyst":1,
"hypercalcemia":1,
"primary hyperparathyroidism":2,
"99mTc-methoxy-isonitrile parathyroid scintigraphy":1,
"Concomitant thyroid pathology":1,
"Concordance":1,
"Concordancia":1,
"Ecografía":1,
"Gammagrafía 99mTc-metoxi-isobutil-isonitrilo (MIBI)":1,
"Gland weight":1,
"Hiperparatiroidismo primario":1,
"Patología tiroidea concomitante":1,
"Peso glandular":1,
"Sensibilidad":1,
"Sensitivity":1,
"Ultrasound":8,
"2015 American Thyroid Association management guideline":1,
"medullary thyroid carcinoma":9,
"papillary thyroid carcinoma":45,
"thyroid imaging reporting and data system":1,
"Lymph node metastases":1,
"Multifocality":1,
"Recurrence-free survival":3,
"Total tumor diameter":1,
"FDG-PET":1,
"Liver recurrence":1,
"Lung recurrence":1,
"Pancreatic cancer":1,
"Prognosis":16,
"PD-1 inhibitor":1,
"hypothyroidism":3,
"immune checkpoint inhibitor (ICI)":1,
"thyroid":13,
"tyrosine kinase inhibitor":1,
"Colloid goiter":1,
"Metals":1,
"Oxidative stress":2,
"Acinic cell carcinoma":1,
"Beta-catenin":1,
"Cyclin D1":1,
"High grade transformation of acinic cell carcinoma":1,
"N-glycoproteomics":1,
"combinatorial peptide ligand library":1,
"mass spectrometry":1,
"Bcl-2":1,
"acetylation":1,
"microRNA-203":1,
"survivin":1,
"Autophagy":1,
"CyclinD1":1,
"HULC":1,
"PKM2":1,
"miR675":1,
"Central compartment dissection":1,
"Extra thyroidal extension":1,
"Recurrent laryngeal nerve":2,
"Thyroidectomy":14,
"Tracheo-esophageal groove":1,
"carcinoma":6,
"surveillance":1,
"thyroid neoplasm":3,
"autoimmune thyroiditis":1,
"mutagenesis":1,
"mutational profiling":1,
"next-generation sequencing (NGS)":1,
"variant allele frequencies (VAF)":1,
"alpha-fetoprotein":1,
"long non-coding RNA":2,
"overall survival":1,
"prognostic marker":1,
"thyroid hormone":1,
"EGFR":1,
"Immunohistochemistry":4,
"Lung cancer":1,
"Molecular testing":1,
"Sequencing":1,
"TTF-1":2,
"differentiated thyroid carcinoma":3,
"iodine scan":1,
"therapeutic response":3,
"thyroglobulin":5,
"Abdominal pain":1,
"Bile acid malabsorption":1,
"Bloating":1,
"Cancer":6,
"Chemotherapy":3,
"Consequences of treatment":1,
"Diarrhoea":1,
"Endoscopy":2,
"Gastrointestinal":1,
"Gynaecological malignancy":1,
"Incontinence":1,
"Late effects":1,
"Quality of life":2,
"Radiotherapy":3,
"Side effects":1,
"Small intestinal bacterial overgrowth":1,
"Toxicity":1,
"Urgency":1,
"Hyperthyroidism":2,
"Hypoglycemia":1,
"Insulinoma":1,
"Myxedema coma":1,
"Paraganglioma":1,
"Pheochromocytoma":2,
"Thyrotoxicosis":2,
"DNA methylation":1,
"RASSF1 protein":1,
"SLC5A8 protein":1,
"biomarker":2,
"circulating tumor DNA":1,
"human":1,
"mutation":1,
"papillary":1,
"proto-oncogene proteins B-raf":1,
"lymph node metastasis":3,
"nomogram":4,
"radiomics":2,
"shear-wave elastography":1,
"Kuma":1,
"high risk":1,
"low risk":2,
"microcarcinoma":2,
"ATC":1,
"Artesunate":1,
"Chemoresistance":1,
"Mitochondria":1,
"Sistrunk":1,
"Thyroglossal duct cyst":1,
"Thyroid carcinoma":12,
"FAM49B":1,
"Gallbladder cancer":1,
"PI3K/AKT pathway":1,
"TASP1":1,
"Tumor progression":1,
"corticosteroids":1,
"hyperkalaemia":1,
"immunotherapy":2,
"nephritis":1,
"CEFTE":1,
"CytoFoam Core":1,
"EWSR1 rearrangement":1,
"Ewing sarcoma":1,
"Small cell carcinoma":2,
"Extrathyroidal extension":2,
"Recurrence":6,
"Tumor size":3,
"depth of invasion (DOI)":1,
"magnetic resonance imaging (MRI)":1,
"oral cavity":1,
"squamous cell cancer (SCC)":1,
"tumor thickness":1,
"Destructive thyroiditis":1,
"Hepatocellular carcinoma":4,
"Lenvatinib":2,
"anti-PD-1 immunotherapy":1,
"anti-thyroid antibodies":1,
"melanoma":1,
"nonsmall-cell lung cancer":1,
"renal cell carcinoma":1,
"thyroid toxicity":1,
"Familial non-medullary thyroid cancer":1,
"Germline":1,
"POT1":1,
"Telomere":1,
"JNK signaling pathway":1,
"KLF5":1,
"anaplastic thyroid carcinoma":10,
"chemotherapy sensitivity":1,
"Hypoparathyroidism":2,
"hypocalcemia":3,
"risk factors":2,
"total thyroidectomy":1,
"Positron emission tomography":1,
"positron emission tomography associated incidental neoplasms":1,
"thyroid incidentalomas":1,
"Central Neck Dissection":1,
"Locoregional Recurrence":1,
"Lymph Node":2,
"Head and neck tumor":1,
"Operative technique":1,
"Robotic neck surgery":1,
"Surgical procedure":1,
"Therapeutics":1,
"Thyroid neoplasms":11,
"continuous neural monitoring":1,
"porcine model":1,
"thyroid surgery":2,
"transcutaneous electric stimulation":1,
"Apoptosis":1,
"Cell cycle":1,
"Gallbladder carcinoma":1,
"JAK2/STAT3":1,
"S-adenosylmethionine":1,
"Anaplastic thyroid":1,
"Pleomorphic giant cells":1,
"Poorly differentiated thyroid carcinoma":1,
"Follicular thyroid carcinoma":3,
"Histological variants":1,
"ACC, adrenocortical carcinoma":1,
"AUC, area under the curve":1,
"Algorithm":1,
"BLCA, bladder urothelial carcinoma":1,
"BRCA, breast invasive carcinoma":1,
"CESC, cervical squamous cell carcinoma and endocervical adenocarcinoma":1,
"CHOL, cholangiocarcinoma":1,
"COAD, colon adenocarcinoma":1,
"CV, cross validation":1,
"Classification":1,
"DLBC, lymphoid neoplasm diffuse large B-cell lymphoma":1,
"ESCA, esophageal carcinoma":1,
"GBM, glioblastoma multiforme":1,
"GEO, Gene Expression Omnibus":1,
"GO, gene ontology":1,
"Gene expression profiling":1,
"HNSC, head and neck squamous cell carcinoma":1,
"KICH, kidney chromophobe":1,
"KIRC, kidney renal clear cell carcinoma":1,
"KIRP, kidney renal papillary cell carcinoma":1,
"LAML, acute myeloid leukemia":1,
"LGG, brain lower grade glioma":1,
"LIHC, liver hepatocellular carcinoma":1,
"LUAD, lung adenocarcinoma":1,
"LUSC, lung squamous cell carcinoma":1,
"MESO, mesothelioma":1,
"MSI, microsatellite instability":1,
"MSS, microsatellite stability":1,
"Machine learning":1,
"Microsatellite instability":1,
"OV, ovarian serous cystadenocarcinoma":1,
"PAAD, pancreatic adenocarcinoma":1,
"PCPG, pheochromocytoma and paraganglioma":1,
"PPI, protein-protein interaction":1,
"PRAD, prostate adenocarcinoma":1,
"READ, rectum adenocarcinoma":1,
"RF, random forest":1,
"ROC, receiver operating characteristic":1,
"SARC, sarcoma":1,
"SKCM, skin cutaneous melanoma":1,
"STAD, stomach adenocarcinoma":1,
"SVM, support vector machine":1,
"TCGA, The Cancer Genome Atlas":1,
"TGCT, testicular germ cell tumors":1,
"THCA, thyroid carcinoma":1,
"THYM, thymoma":1,
"UCEC, uterine corpus endometrial carcinoma":1,
"UCS, uterine carcinosarcoma":1,
"UVM, uveal melanoma":1,
"XGBoost, extreme gradient boosting":1,
"k-NN, k-nearest neighbor":1,
"gut microbiome":1,
"prion-like":1,
"radioiodine refractory":1,
"sodium/iodide symporter":1,
"virome":1,
"cystic lymph node metastasis":1,
"cystic node metastasis":1,
"lateral neck lymph node metastasis":1,
"lateral neck metastasis":1,
"BRAF":5,
"RAS":2,
"TERT":1,
"undifferentiated thyroid carcinoma":1,
"LOXO-292":1,
"RET":2,
"gene fusion":1,
"tumor genomic profiling":1,
"caveolin-1":1,
"thyroid function":1,
"Age":1,
"BRAF mutation":1,
"Papillary thyroid cancer":9,
"cervical lymph node metastasis":2,
"contrast-enhanced ultrasound":2,
"conventional ultrasound":1,
"Diagnostic imaging":2,
"Meta-analysis":5,
"Systematic review":2,
"Ultrasonography":5,
"circulating microRNAs":1,
"diagnosis":2,
"SMARCB1":1,
"aneuploidy":1,
"integrase interactor 1":1,
"Lymph node ratio":1,
"Survival":4,
"germ cell tumor":1,
"malignant struma ovarii":1,
"teratoma":1,
"Hereditary":1,
"PDL-1":1,
"breast cancer":6,
"neuroendocrine cancer":1,
"small cell cancer":1,
"adolescents":1,
"incidence":2,
"trends":1,
"young adults":1,
"Endocrine":1,
"Ki-67":1,
"Ki67":1,
"Proliferation":2,
"Parathyroid carcinoma":1,
"Aging":1,
"Disease-specific mortality":1,
"endocrine surgery":1,
"imaging":1,
"parathyroid hormone level":1,
"parathyroidectomy":2,
"surgical volumes":1,
"Clinicopathologic features":1,
"Follicular variant of papillary thyroid carcinoma":1,
"Liver":1,
"Synchronous":2,
"Thyroid-like cholangiocarcinoma":1,
"Congenital abnormalities":1,
"Multidetector computed tomography":1,
"Thyroid diseases":1,
"Thyroid function tests":1,
"Thyroid gland":5,
"CD10":1,
"CD15":1,
"radioactive iodine":1,
"BRAFV600E mutation":1,
"central cervical lymph node metastasis":1,
"predictive model":1,
"Case-mix":1,
"Casuística":1,
"Complejidad":1,
"Complexity":1,
"Consultas externas":1,
"Endocrinology":1,
"Endocrinología":1,
"Nutrición":1,
"Nutrition":1,
"Outpatient care":1,
"Anti-idiotypic antibody":1,
"Breast cancer cell":1,
"Insulin":1,
"Insulin receptor":1,
"Signaling pathway":1,
"SBRT":1,
"canine":1,
"stereotactic":1,
"Pediatric age":1,
"malignant tumor":1,
"metabolic syndrome":1,
"neoplasms":2,
"obesity":1,
"PPARγ":1,
"SDF1/CXCR4 signaling":1,
"chaperone-mediated autophagy":1,
"Syngnathid":1,
"electron microscopy":1,
"neoplasia":1,
"pipefish":1,
"seahorse":1,
"Merkel cell carcinoma":1,
"carcinoid":1,
"cytology":2,
"insulinoma-associated protein 1 (INSM1)":1,
"neuroblastoma":1,
"pancreatic":1,
"smear":1,
"Cell proliferation":4,
"KIF15":1,
"Metastasis":4,
"Migration":2,
"Cognitive impairment":1,
"Rats":1,
"TSH suppression therapy":1,
"mTOR signaling pathway":1,
"immune-associated genes":1,
"prognostic signature":1,
"Follicular adenoma":1,
"Follicular variant":1,
"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"Papillary carcinoma":5,
"advanced differentiated thyroid cancer":1,
"anaplastic thyroid cancer":2,
"differential diagnosis":2,
"systemic inflammatory marker":1,
"Central lymph node metastasis":3,
"Nomograms":1,
"Epithelial to mesenchymal transition":1,
"Fibroblast growth factor receptor 4":1,
"Gastric neoplasms":1,
"Gly388Arg polymorphism":1,
"STAT3":1,
"CHI3L1":1,
"CYR61":2,
"angiogenesis":2,
"invasion":4,
"2-amino-3-(4-((5-amino-2-phenylbenzo(d)oxazol-7-yl)methoxy)-3,5-dichlorophenyl)propanoic acid":1,
"Amino acid transport systems":1,
"Boron neutron capture therapy":1,
"Large neutral amino acid-transporter 1":1,
"Proto-oncogene proteins c-myc":1,
"Larynx":2,
"laryngectomy":2,
"squamous cell carcinoma":2,
"thyroid gland invasion":1,
"challenges for innovative therapies":1,
"treatments and obstacles":1,
"Adjuvant therapy":1,
"Differentiated thyroid cancer":2,
"Intermediate-to-high risk":1,
"Retrospective study":1,
"BANCR":1,
"BRAFV600E":3,
"Predictive biomarkers":1,
"Cost-effectiveness analysis":1,
"Fine-needle aspiration biopsy":1,
"Screening test":1,
"Serum calcitonin":1,
"Thyroid nodule":9,
"AJCC staging system":1,
"SEER":2,
"TNM staging system":1,
"Postsurgical hypothyroidism":1,
"Thyroid lobectomy":2,
"mendelian randomization":1,
"molecular epidemiology":1,
"thyrotropin":1,
"Children":1,
"Pediatric":2,
"Toxic nodule":1,
"Deep convolutional neural network":1,
"Deep learning":3,
"Thyroid nodule classification":1,
"MicroRNAs":1,
"epithelial-mesenchymal transition":2,
"miR-199a-5p":1,
"Incidental thyroid nodule":1,
"cervical spine":1,
"computed tomography":1,
"magnetic resonance imaging":1,
"Cellular immunotherapy plus chemotherapy":1,
"Favorable outcome":1,
"Gastric cancer":2,
"Neoplasm staging":1,
"Preoperative care":1,
"Active surveillance":4,
"Lymphovascular invasion":1,
"TERT promoter Mutation":1,
"follicular cell derived thyroid cancer":1,
"metastatic thyroid cancer":1,
"pleural effusion":1,
"prognostic factors":1,
"HIFU":1,
"ablation":1,
"benign":1,
"nodules":1,
"COVID-19":1,
"Coronavirus":1,
"Infectious disease":1,
"Autologous breast reconstruction":1,
"Composite nipple grafting":1,
"Contralateral breast cancer":1,
"Deep inferior epigastric perforator flap":1,
"Donor nipple":1,
"Invasive cancer of graft":1,
"Nipple graft":1,
"Nipple-areola complex reconstruction":1,
"Reconstructed nipple":1,
"disease prognosis":1,
"matrix metalloproteinase-2":1,
"matrix metalloproteinase-9":1,
"radiofrequency ablation":1,
"serum level":1,
"epithelial-to-mesenchymal transition":1,
"microRNA 200b":1,
"vimentin":1,
"zinc finger E-box binding homeobox 1":1,
"PTC":5,
"RAB5C":1,
"miR-145":1,
"Han Chinese population":1,
"IL-1RN":1,
"genetic polymorphism":1,
"AUC":1,
"IPGS":1,
"Immune infiltrating":1,
"Diagnostic test performance":1,
"Thyroglobulin doubling time":1,
"[18F]FDG PET/CT":1,
"3D tumor model":1,
"Doxorubicin":1,
"Polymeric scaffold":1,
"Stem cell markers":1,
"Breast sarcoma":1,
"Cowden’s syndrome":1,
"PTEN":1,
"AIP":1,
"Acromegaly":1,
"Acromégalie":1,
"Cancer thyroïdien":1,
"FIPA":1,
"GATA-3":1,
"fine-needle aspiration":2,
"parathyroid adenoma":1,
"parathyroid hormone":1,
"Internal echogenicity":1,
"Microcalcification":1,
"Thyroid papillary carcinoma":2,
"Ultrasounds":1,
"Breast":1,
"endocrine hormone":1,
"mastectomy":1,
"synchronous cancer":1,
"Cholangiocarcinoma":1,
"pyruvate kinase M2":1,
"reactive oxygen species":2,
"shikonin":1,
"DPP4":1,
"FosB":1,
"KAT5":1,
"p62/Keap1/Nrf2 signaling":1,
"arteriovenous malformation":1,
"Late recurrence":1,
"positron-emission tomography/computed tomography":1,
"STAT6":1,
"checkpoint blockade":1,
"immune":1,
"marker":1,
"guidelines":1,
"Case report":3,
"Minimally invasive thyroidectomy":1,
"FNAB":1,
"Metastatic adenocarcinoma":1,
"Neck":1,
"Prostate adenocarcinoma":1,
"Akt":1,
"CKS1B":1,
"STAT3/PD-L1":1,
"ALK":1,
"NTRK":1,
"ROS1":1,
"pan-Trk":1,
"lncRNA HULC":1,
"lncRNA PTCSC3":1,
"Lateral aberrant thyroide":1,
"Pseudoanvrysm":1,
"endoscopic":1,
"transoral":1,
"vestibular approach":1,
"levothyroxine":2,
"medication adherence":1,
"medication beliefs":1,
"Biology":1,
"Calcitonin":1,
"Medullary":1,
"Chemiluminescence":1,
"Cytochrome P450 reductase":1,
"Cytochrome b5-reductase":1,
"Nontoxic nodular goiter":1,
"Toxic goiter":1,
"Bone metastasis":1,
"Carcinoma papilar":1,
"Glándula tiroides":1,
"HBME-1":1,
"Inmunohistoquímica":1,
"Metástasis ósea":1,
"Napsin-A":1,
"Napsina-A":1,
"PAX-8":1,
"central-compartment lymph node metastasis":1,
"clinical N0":1,
"predictive factors":1,
"strap muscle invasion":1,
"ER stress":1,
"GRP78":1,
"Tunicamycin":1,
"clinical trial":1,
"phase III":1,
"precision medicine":1,
"sentinel lymph node":1,
"stomach neoplasms":1,
"Adolescent and young adult":1,
"Korea":2,
"Oncology: Endocrine":1,
"axillary lymph node":1,
"metastases":1,
"radioiodine":1,
"Familial non medullary thyroid cancer":1,
"Familial papillary thyroid cancer":1,
"Syndromic thyroid cancer":1,
"Hobnail variant papillary thyroid cancer":1,
"THADA/IGF2BP3":1,
"ThyroSeq v3":1,
"atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS)":1,
"benign call rate":1,
"follicular or oncocytic (Hurthle cell) neoplasm/suspicious for a follicular or oncocytic (Hurthle cell) neoplasm (FN/SFN)":1,
"indeterminate cytology":1,
"rate of malignancy":1,
"Risk assessment":1,
"Neuroprotection":1,
"Oral vestibular":1,
"Surgical procedures, minimally invasive":1,
"Endoscope":1,
"Parathyroid":1,
"Hürthle cell lesions":1,
"Hürthle cell neoplasm":1,
"molecular alterations":1,
"Epithelial mesenchymal transformation":1,
"Lncrna mir503hg":1,
"Mir-15b":1,
"Pdcd4":1,
"education":1,
"fellowship":1,
"otolaryngology":1,
"training":1,
"Clinicopathologic factors":1,
"lymph node resection":1,
"papillary thyroid microcarcinoma":3,
"sonographic features":1,
"Graves’ disease":1,
"CLDN1":1,
"lncRNA XIST":1,
"miR-101-3p":1,
"LMO4":1,
"circ_0058124":1,
"miR-370-3p":1,
"functional outcomes":1,
"survival outcomes":1,
"PET-CT":1,
"Breast cancer-specific mortality":1,
"Stage IV":1,
"RNA":1,
"conformal":1,
"organ at risk":1,
"radiation dose":1,
"thioredoxin":1,
"thioredoxin interacting protein":1,
"tissue array":1,
"tumorigenesis":1,
"xenograft":1,
"Esophageal squamous cell carcinoma":1,
"Lymph nodes":2,
"STRN-ALK fusion":1,
"fine needle aspiration cytology":2,
"molecular profiling":1,
"calcifications":1,
"osteopontin":1,
"psammoma bodies":1,
"5′-Nucleotidase":1,
"CD73":1,
"epithelial–mesenchymal transition":2,
"tumor microenvironment":2,
"lateral neck dissection":1,
"lymph node yield":1,
"radioiodine uptake":1,
"Biomarkers":1,
"Disease staging":1,
"Medullary thyroid cancer":1,
"Medullary thyroid neoplasm":1,
"cfDNA":1,
"microRNA":1,
"Anterior mediastinum":1,
"mass":1,
"18F-FDG":1,
"PET/CT":1,
"CTGF":1,
"FOXK1":1,
"Progression":1,
"Lung metastasis":1,
"Pneumothorax":1,
"Buccal squamous cell carcinoma":1,
"Early-stage tumor":1,
"Oral squamous cell carcinoma":1,
"Submandibular gland preservation":1,
"Survival analysis":1,
"Segmentation":1,
"diagnostic pitfalls":1,
"parathyroid lesion":1,
"thyroid lesion":1,
"EU-TIRADS":1,
"FNA":1,
"Hürthle cell":1,
"thyroid ultrasonography":1,
"ADAM10":1,
"JAK-STAT signaling pathway":1,
"long non-coding RNA LUCAT1":1,
"microRNA-493":1,
"Gene Expression Omnibus database":1,
"bioinformatics analysis":1,
"differential expressed genes":1,
"IL-6":1,
"OVV":1,
"circRNA_103598":1,
"miR-23a-3p":1,
"dielectric properties":1,
"open-ended coaxial line":1,
"thyroid nodules":1,
"AGK-BRAF":1,
"RET/PTC":1,
"genomic instability":1,
"nuclear architecture":1,
"low-risk thyroid cancer":1,
"overdiagnosis":2,
"overtreatment":3,
"Biopsy, Fine needle":1,
"BRAF V600E":1,
"Dabrafenib and trametinib":1,
"Rechallenge":1,
"Lung neoplasms":1,
"Neoplasm invasiveness":1,
"TRIP13":1,
"Wnt signaling pathway":1,
"Level vi":1,
"Nodal metastases":1,
"Occult":1,
"prediction model":1,
"contralateral occult carcinoma":1,
"ipsilateral occult carcinoma":1,
"surgery":2,
"clinicopatholigical":1,
"outcomes":1,
"EORTC QLQ-C30":1,
"EORTC QLQ-H&amp":1,
"HNSCC":1,
"N43":1,
"free flap":1,
"head and neck squamous cell carcinoma":1,
"mandible composite reconstruction":1,
"prosthetic rehabilitation":1,
"surgical treatment":1,
"acoustic radiation force impulse":1,
"prophylactic central neck dissection":1,
"AUS":1,
"CXCL12":1,
"Cell block":1,
"The Bethesda System for Reporting Thyroid Cytopathology":1,
"liquid-based cytology":1,
"Breast neoplasms":1,
"Hormone receptor":1,
"Vitamin D":1,
"immunophenotype":1,
"pathogenesis":1,
"Chronic lymphocytic leukemia":1,
"Malignant melanoma":1,
"Second primary malignancy":1,
"Squamous carcinoma":1,
"Hypopharynx":1,
"Thyroid cartilage":1,
"buccal mucosa squamous cell carcinoma":1,
"cell-in-cell":1,
"disease-specific survival":1,
"frequency of heterotypic neutrophil-in-tumor structure":1,
"Cell-free DNA (cfDNA)":1,
"cardiovascular disease (CVD)":1,
"radioactive iodine treatment (RAI treatment)":1,
"Lobectomy":1,
"thyrotropin (TSH)":1,
"central neck dissection (CND)":1,
"intact parathyroid hormone (iPTH)":1,
"morbidity":1,
"Cancer biomarker":1,
"telomerase":1,
"telomerase reverse transcriptase promoter mutations (TERT promoter mutations)":1,
"thyroid carcinoma (TC)":1,
"ETV6 rearrangement":1,
"Head and neck cancer":1,
"Mammary analog secretory carcinoma":1,
"TRK inhibitor":1,
"breast cancer risk":1,
"infertility":1,
"radiation-induced thyroid cancer":1,
"radioiodine therapy":1,
"CIBERSORT":1,
"TCGA":1,
"immune cell infiltration":1,
"immune escape":1,
"autophagy-associated genes":1,
"the cancer genome atlas":2,
"Breast invasive ductal carcinoma":1,
"Function enrichment analysis":1,
"Glycolysis":1,
"Iodine radioisotopes":1,
"Thyroid cancer, papillary":1,
"HEMGN":1,
"PI3K/Akt signal pathway":1,
"circ_PSD3":1,
"miR-637":1,
"Oropharyngeal squamous cell carcinoma (OPSCC)":1,
"concurrent chemoradiotherapy (CRT)":1,
"cytokeratin 19 soluble fragment (Cyfra21-1)":1,
"External Auditory Canal":1,
"Metastatic NPC":1,
"Nasopharyngeal carcinoma":1,
"Treatment of NPC":1,
"China":2,
"Italy":1,
"Premenopause":1,
"Surgical oncology":1,
"differentiated thyroid carcinoma (DTC)":1,
"minimally invasive surgery":1,
"Anaplastic thyroid carcinoma (ATC)":1,
"Thyroid Imaging Reporting and Data System (TI-RADS)":1,
"contrast-enhanced ultrasound (CEUS)":1,
"superb micro-vascular imaging (SMI)":1,
"Autofluorescence":1,
"near-infrared":1,
"parathyroid gland":1,
"Thyroid cytology":1,
"modifications":1,
"terminology":1,
"papillary microcarcinoma":2,
"patient age":1,
"FNA cytology":1,
"active surveillance (AS)":1,
"borderline lesions":1,
"follicular cells":1,
"indolent lesion of epithelial origin":1,
"indolent lesion of epithelial origin (IDLE)":1,
"low-risk carcinomas":1,
"precursor lesions":1,
"Atypia of undetermined significance/follicular lesion of undetermined significance thyroid (AUS/FLUS thyroid)":1,
"Indian":1,
"resection rate (RR)":1,
"risk of malignancy (ROM)":1,
"distant metastasis":1,
"follicular carcinoma":1,
"metachronous":1,
"Asia":1,
"Japan":1,
"papillary thyroid carcinoma (PTC)":1,
"class III beta-tubulin":1,
"molecular oncology":1,
"predictive molecular pathology":1,
"prognostic biomarker":1,
"RET gene":1,
"multiple endocrine neoplasia-IIb":1,
"Carbon nanoparticles":1,
"Indocyanine green":1,
"Near-infrared laparoscopy":1,
"Shear wave elastography":1,
"deuxième néoplasme primitif":1,
"effets des radiations":1,
"néoplasme thyroïdien":1,
"radiation effects":1,
"radiothérapie":1,
"second primary neoplasm":1,
"thorax":1,
"LINC00324":1,
"TRIM29":1,
"miR-195-5p":1,
"cancer cell stemness indices":1,
"head and neck squamous cell carcinomas":1,
"predictive models":1,
"weighted gene co-expression network analysis":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2020年10月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
